Department of Pediatrics, Subdivision of Endocrinology, Erasmus MC/Sophia Children's Hospital, Rotterdam, the Netherlands.
Clin Endocrinol (Oxf). 2010 Jun;72(6):775-80. doi: 10.1111/j.1365-2265.2010.03771.x. Epub 2010 Jan 25.
BACKGROUND/OBJECTIVES: Acylation-stimulating protein (ASP) is an adipose tissue-derived hormone, which stimulates glucose and free fatty acid (FFA) uptake into adipocytes. Changes in ASP metabolism are associated with alterations in lipid metabolism. As postnatal catch-up growth has been associated with dyslipidaemia in later life, we investigated the association between ASP and birth size, adult size and different growth patterns during childhood.
The associations were investigated by multiple regression analyses in 285 young adults, aged 18-24. Subsequently, differences in ASP were analysed in four clinically relevant subgroups, young adults either born small for gestational age with short stature (SGA-S) or with catch-up growth (SGA-CU), or born appropriate for gestational age with idiopathic short stature (ISS) or with normal stature (controls).
Weight gain during childhood, particularly fat accumulation, was positively related to ASP levels in early adulthood, independent of birth size, age and gender. Foetal growth, reflected by birth size, was not related to ASP levels. Between the subgroups, no differences in ASP were found, but SGA-CU and ISS subjects had significantly higher levels of FFA.
Exaggerated weight gain during childhood, but not foetal growth, contributes to alterations in ASP metabolism, which may be associated with impaired FFA uptake and delayed triglycerides clearance. Therefore, exaggerated weight gain during childhood should be prevented.
背景/目的:酰化刺激蛋白(ASP)是一种脂肪组织来源的激素,可刺激葡萄糖和游离脂肪酸(FFA)进入脂肪细胞摄取。ASP 代谢的变化与脂质代谢的改变有关。由于出生后追赶生长与成年后血脂异常有关,我们研究了 ASP 与出生体重、成人身高和儿童期不同生长模式之间的关系。
在 285 名 18-24 岁的年轻成年人中,通过多元回归分析研究了这些关联。随后,在四个具有临床意义的亚组中分析了 ASP 的差异,这些亚组分别为:出生时为小于胎龄儿且身材矮小(SGA-S)或有追赶生长(SGA-CU)的成年人、出生时为适于胎龄儿且为特发性身材矮小(ISS)或身材正常的成年人(对照组)。
儿童期体重增加,尤其是脂肪堆积,与成年早期的 ASP 水平呈正相关,与出生体重、年龄和性别无关。出生体重反映的胎儿生长与 ASP 水平无关。在亚组之间,ASP 没有差异,但 SGA-CU 和 ISS 患者的 FFA 水平显著升高。
儿童期过度的体重增加,而不是胎儿生长,会导致 ASP 代谢的改变,这可能与 FFA 摄取受损和甘油三酯清除延迟有关。因此,应预防儿童期过度的体重增加。